Literature DB >> 23392133

Angiotropism in primary cutaneous melanoma with brain metastasis: a study of 20 cases.

Tawny Hung1, Jason Morin, William R Munday, Ian R A Mackenzie, Claire Lugassy, Raymond L Barnhill.   

Abstract

Previous clinical and experimental studies suggested that invasion of the brain by metastatic melanoma may follow the external surfaces of vascular channels, that is, angiotropic extravascular migratory metastasis. Such angiotropic invasion seemss analogous to that of neoplastic glial invasion of the nervous system. We, therefore, have retrospectively investigated 20 primary melanoma cases and their respective metastatic brain lesions. The following parameters were analyzed in each primary melanoma: presence of angiotropism, Breslow thickness, Clark level, mitotic rate, sentinel lymph node (SLN) status, and time interval between the primary lesion and the metastasis. The metastatic brain lesions were examined for the presence of angiotropism. Of the 20 cases, 14 showed angiotropism in the primary lesion. The angiotropic group had a significantly deeper Breslow thickness (median 4.4 mm vs. 1.4 mm, P < 0.01) and was more mitotically active (median 11 vs. 4.7 mitoses/mm, P = 0.04). Interestingly, the angiotropic group had an average time lapse of 33 months from the primary lesion to the brain metastasis, whereas the nonangiotropic group had a 57-month time interval. Although the Kaplan-Meier analysis failed to show a survival difference in this small cohort (P = 0.235), there was a trend toward significance. Seven of 20 brain metastases showed angiotropism; however, no significant correlation between angiotropism in the primary melanomas and the corresponding metastatic lesions could be demonstrated. Indeed, angiotropism in the brain metastases was difficult to assess because the available material were generally small partial biopsy samplings and many showed conspicuous necrosis. Ten melanoma patients underwent SLN biopsy. The 3 of 6 positive cases in the angiotropic group had an average time lapse of 32 months from the primary lesion to the brain metastasis, whereas the 4 positive SLN biopsies in the nonangiotropic group had an average of 63 months. This preliminary study of angiotropism in primary melanomas and their corresponding brain metastasis shows a striking trend suggesting that angiotropism in primary melanomas may predict the rapid development of brain metastases. This study also has demonstrated the difficulty in studying angiotropism in melanoma brain metastases because of small sample sizes and abundance of necrotic tissue. The authors are in the process of collecting larger and more representative numbers of melanoma brain metastases for further investigations.

Entities:  

Mesh:

Year:  2013        PMID: 23392133     DOI: 10.1097/DAD.0b013e31827e8315AD

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  14 in total

Review 1.  Hyperintense perilesional edema in the brain on T1-weighted images: Cavernous malformation or metastatic melanoma? Three case reports and literature review.

Authors:  Nicolae Sarbu; Teresa Pujol; Laura Oleaga
Journal:  Neuroradiol J       Date:  2016-02-02

2.  Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.

Authors:  Laura J Gardner; Morgan Ward; Robert H I Andtbacka; Kenneth M Boucher; Glen M Bowen; Tawnya L Bowles; Adam L Cohen; Kenneth Grossmann; Ying J Hitchcock; Sheri L Holmen; John Hyngstrom; Hung Khong; Martin McMahon; Marcus M Monroe; Carolyn B Ross; Gita Suneja; David Wada; Douglas Grossman
Journal:  Melanoma Res       Date:  2017-10       Impact factor: 3.599

Review 3.  Non-angiogenic tumours and their influence on cancer biology.

Authors:  Tom Donnem; Andrew R Reynolds; Elizabeth A Kuczynski; Kevin Gatter; Peter B Vermeulen; Robert S Kerbel; Adrian L Harris; Francesco Pezzella
Journal:  Nat Rev Cancer       Date:  2018-03-09       Impact factor: 60.716

4.  Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Authors:  Andrea P Moy; Lyn M Duncan; Stefan Kraft
Journal:  Lab Invest       Date:  2016-12-19       Impact factor: 5.662

5.  Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy.

Authors:  Gary B Deutsch; Richard Tyrell; Samuel Yost; Mariel B Deutsch; Garni Barkhoudarian; Daniel F Kelly; Mark B Faries
Journal:  J Am Acad Dermatol       Date:  2018-02       Impact factor: 11.527

Review 6.  Models and molecular mechanisms of blood vessel co-option by cancer cells.

Authors:  Yu Zhang; Sarah Wang; Andrew C Dudley
Journal:  Angiogenesis       Date:  2019-10-18       Impact factor: 9.596

Review 7.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

8.  The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study.

Authors:  Laila Siam; Annalen Bleckmann; Han-Ning Chaung; Alexander Mohr; Florian Klemm; Alonso Barrantes-Freer; Raquel Blazquez; Hendrik A Wolff; Florian Lüke; Veit Rohde; Christine Stadelmann; Tobias Pukrop
Journal:  Oncotarget       Date:  2015-10-06

9.  Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Einar K Rofstad
Journal:  J Exp Clin Cancer Res       Date:  2015-12-15

10.  Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Einar K Rofstad
Journal:  Transl Oncol       Date:  2016-05-17       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.